From 20 Jan: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through a congressional he... https://arstechnica.com/science/2023/01/ftc-shkreli-may-have-violated-lifetime-pharma-ban-should-be-held-in-contempt/ #daraprim #drug-discovery #druglike #pharma #pharmaceutical-industry #policy #science #shkreli
FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt

Shkreli's latest company, Druglike, may run afoul of his lifetime pharma ban.

Ars Technica